Quantitative detection kit for human chorionic gonadotropin and application of quantitative detection kit
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- XINCHANG COUNTY MEIDI BIOLOGICAL TECH
- Publication Date
- 2014-11-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of medical testing, in particular to a quantitative detection kit for human chorionic gonadotropin and its application. Background technique
[0002] Human chorionic gonadotropin is a glycoprotein secreted by the trophoblast cells of the placenta, which is composed of α- and β-dimer glycoproteins. Among them, the α-subunit is shared with the anterior pituitary hormone, and the β-subunit is specific to human chorionic gonadotropin, which is often used clinically for the diagnosis of early pregnancy. Commonly used early pregnancy test strips detect pregnancy by qualitatively detecting human chorionic gonadotropin in urine. However, in the judgment of abnormal pregnancy and placental function, the diagnosis and condition monitoring of trophoblastic tumors, and the auxiliary diagnosis and condition monitoring of some other tumors, it is necessary to quantitatively detect the concentration of human chorionic gonadotropin ...